Biography
Tudor Jovin, MD
Professor of Neurology
Professor of Neurological Surgery
Director, Cooper Neurological Institute
Education and Training
| Medical School: | Heinrich Heine University, Dusseldorf, Germany |
| Internship: | Internal Medicine - Pennsylvania Hospital, Philadelphia, PA |
| Residency: | Neurology - Pennsylvania Hospital, Philadelphia, PA |
| Fellowship: |
Cerebrovascular/Endovascular - University of Pittsburgh Medical Center, Pittsburgh, PA Neuroendovascular Surgery - University of Pittsburgh Medical Center, Pittsburgh, PA |
Board Certifications
- Neurology
- Vascular Neurology
- Neurocritical Care
- Neuroendovascular Surgery
Memberships
- American Academy of Neurology
- American Association of Neurological Surgeons
- American Heart Association – Stroke Council
- American Neurological Association
- American Society of Neuroimaging
- Society of Vascular and Interventional Neurology
- World Stroke Organization
Awards & Honors
Society of Vascular and Interventional Neurology Pioneering Award, 2015, Society of Vascular and Interventional Neurology Presidential Service Award, 2015, Society of Vascular and Interventional Neurology Distinguished Service Award, 2016, Honorary Member Award, Romanian Society of Stroke, 2017
About Me
Tudor Jovin, MD is Chairman and Chief of Neurology and Medical Director of the Cooper Neurological Institute. He is an expert in interventional and non-interventional treatment for the entire spectrum of stroke and cerebrovascular disorders. He was one of the nation’s first interventional neurologists, a medical subspecialty that uses minimally invasive technologies applied from within the vessels to diagnose and treat diseases of the arteries and veins of the head, neck, and spine such as acute stroke, carotid stenosis, intracranial aneurysm, and arteriovenous malformations.
In addition to his clinical experience, Dr. Jovin is known internationally for his research activities. He has served as principal investigator for several international clinical studies including REVASCAT, a randomized trial of endovascular therapy versus medical therapy for acute stroke within eight hours of symptoms onset conducted in Spain, and DAWN, a multicenter, international, randomized trial of endovascular therapy versus medical therapy in the beyond eight-hour time window. Both studies are considered landmark studies in the development of treatments for acute stroke and have been published in the New England Journal of Medicine. He is a member of the executive or steering committees for several multicenter national and international trials, and has participated as site principal investigator or co-investigator in multiple national and international trials.
Additionally, he serves as editorial board member for numerous medical journals. Dr. Jovin has published more than 300 articles in peer-reviewed journals or book chapters. The consequential nature of his research is evidenced by recently published studies that have identified Dr. Jovin as the highest impact author in the neuro-interventional field.
Prior to joining Cooper, Dr. Jovin was a professor of neurology and neurosurgery at the University of Pittsburgh School of Medicine and director of the Center for Neuroendovascular Therapy at the University of Pittsburgh Medical Center (UPMC). At UPMC, he also served as the director of UPMC’s Stroke Institute, one of the leading centers for stroke care, education, and research in the world.